drugset / Trial / NCT03417661

An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes

NCT03417661

Phase 3 Completed 93 enrolled Gama Healthcare Ltd.
RandomizedParallel-groupDouble-blindOther

Summary

This study evaluates the antimicrobial properties of HEXI-PREP by Clinell compared to both a negative and a positive control product.

Timeline

Start
2018-06-29
Primary completion
2019-06-06
Completion
2019-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 3 ml Topical
Subject HEXI-PREP Unknown 3 ml Topical

Indications

No indication recorded.